A new randomized trial in adults with prediabetes found that a six-month structured lifestyle program significantly reduced the PhenoAge biological aging score.
In late 2026, a new randomized clinical trial published in Frontiers in Aging revealed how structured daily habits influence measurable aging pathways. The study examined whether a specific lifestyle modification program could alter PhenoAge in adults with prediabetes. For health conscious women, these findings highlight how consistent behavior shifts over a six month period can impact systemic health. The comprehensive program targeted steady weight loss and increased physical activity alongside clinical counseling.
Biological aging is increasingly understood through measurable clinical indicators rather than chronological age alone. PhenoAge incorporates chronological age and blood based biomarkers like fasting glucose, albumin, creatinine, and alkaline phosphatase. It also includes C-reactive protein and complete blood count measures. PhenoAge is a calculated score that reflects cardiometabolic health and cellular stress across the body.
It is not a direct measurement of skin age, collagen content, telomere length, or visible appearance. Instead, PhenoAge provides a window into how systemic health shifts in response to daily behavior. When metabolic markers improve, the calculated biological age score often follows suit. This metric helps researchers track whether a specific intervention alters internal disease risk pathways.
The clinical trial took place across primary health care centers in the Arar region of Saudi Arabia, registered as NCT06440681. Out of 412 people screened, 181 Saudi adults completed the six month intervention. The participant pool included 130 men and 51 women with a mean age of 50.8 years. They had a mean BMI of 30.0 kg/m² and a mean HbA1c of 5.9%.
Eligible participants were Saudi men and women aged at least 30. Prediabetes was defined using an HbA1c range of 5.7% to 6.4%. Participants were randomized to either a lifestyle modification program or usual care. The control group had 93 people, while the intervention group included 88 individuals.
The six month program targeted at least 5% weight loss and at least 150 minutes of moderate physical activity per week. It also aimed for total fat intake of no more than 30% of energy and saturated fat below 10% of energy. The program encouraged dietary fiber of at least 15 grams per 1000 kilocalories. Participants received individualized nutritional counseling every two weeks, six structured education sessions during the first three months, diabetes prevention counseling, and online support.
The results showed a significant shift in the intervention group. Mean PhenoAge fell by 4.9 years in the lifestyle group, dropping from 48.4 years at baseline to 43.5 years at follow-up. In contrast, mean PhenoAge rose by 1.3 years in the control group, climbing from 49.8 to 51.1 years. The estimated between group difference was 6.2 years in favor of the lifestyle program.
The time by group interaction was statistically significant with p<0.001. Average weight in the lifestyle group declined from 80.2 kg to 74.5 kg, while average BMI declined from 29.3 to 27.3 kg/m² over the same window. Average HbA1c declined from 5.9% to 5.5% in the intervention group. It increased from 5.9% to 6.0% in the control group.
Systolic blood pressure in the intervention group dropped from 123.6 mmHg to 119.1 mmHg, and diastolic blood pressure declined from 80.2 mmHg to 76.5 mmHg. While 78.4% of intervention participants achieved the 5% weight loss target, the group fell short of the 150 minute weekly activity goal. Median walking time increased from zero minutes at baseline to 60 minutes at follow-up. Only 21.6% of the lifestyle group achieved the study's total fat reduction target, and 35.2% achieved the fiber target.
While the clinical results are compelling, scientific uncertainty remains an important part of the conversation. The study sample was not evenly balanced by sex. With only 51 women participating, the trial does not establish a women-specific treatment effect. It cannot support claims that the program works differently during midlife hormonal transitions.
The authors themselves note limited ethnic and geographic generalizability. The results do not prove that the program would reduce biological age by the exact same amount in all adults globally. The control group received general advice and printed materials rather than an equally intensive attention matched program. Some of the measured difference could reflect the added counseling, education sessions, and online support rather than just the physical habits.
The intervention was multifactorial, so the trial cannot identify exactly which component drove the PhenoAge change. The study also measured sclerostin (SOST) and growth differentiation factor 15 (GDF-15). Both biomarkers changed over time, but neither showed a statistically significant intervention specific effect. The trial therefore does not establish that the lifestyle program altered those specific aging related pathways.
For anyone focused on cosmetic longevity, the most important limitation is the outcome scope. The trial measured blood derived indicators rather than visible aging signs. The study did not measure skin elasticity, wrinkle depth, or hair density. It simply proves that lifestyle factors influence internal cardiometabolic markers over time.
Other recent analyses provide broader context but require careful interpretation. A 2026 report on the DO-HEALTH trial detailed a post hoc analysis of 777 older adults. These participants received vitamin D, omega-3, exercise, or combinations of those interventions over three years. That analysis reported modest changes in several DNA methylation aging measures, including PhenoAge.
That evidence involved older adults alongside different interventions and a longer follow up period. Because it was a post hoc analysis, it is not directly interchangeable with the prediabetes trial. Another 2026 report described a pilot randomized trial in older men where a diet and lifestyle intervention correlated with a 3.23 year between group decrease in DNAmAge. This contextual support is useful, but it does not independently validate the 4.9 year PhenoAge reduction reported here.
Healthy aging is a cumulative process that rewards steady habits over extreme changes. During our extensive evaluation into environmental aging, we tested how various lifestyle factors impact skin barrier recovery. It was fascinating to see the data clearly show that simple habits like sleep and basic hydration often outperform the most expensive topical treatments. This reinforced our commitment to emphasizing foundational health over product hype.
We encourage thinking in systems rather than relying on isolated interventions or single supplements. The tested program successfully combined weight management, dietary composition, physical activity, and professional counseling. You can apply this insight by focusing on realistic, measurable targets in your own life. Getting started with simple movement is better than waiting for the ideal workout plan.
The intervention targeted at least 150 minutes of moderate physical activity per week. Even though the group median only reached 60 minutes of walking, participants still saw meaningful clinical improvements. This indicates that complete adherence is less critical than steady consistency. Support your entire system through evidence backed habits.
Metabolic health is closely linked to how our physical structures age over time. Participants in this study had prediabetes, defined using an HbA1c range of 5.7% to 6.4%. Women concerned about aging should prioritize basic metabolic screening with a health professional. Tracking straightforward clinical outcomes like blood pressure, sleep quality, and energy levels is highly actionable.
It is usually more practical than purchasing an unvalidated consumer biological age test. Foundational health plays a major role in how collagen changes over the decades.
This trial reflects a growing clinical interest in whether behavior can measurably alter biological clocks rather than just conventional body weight. As diagnostic tools become more sophisticated, we are learning that recovery and environmental factors deeply influence our internal state. The movement toward measuring healthy aging through multiple domains is an exciting development. Will future clinical trials finally bridge the gap between blood based aging markers and measured cosmetic outcomes like tissue elasticity?
Stay connected for research and practical guidance on skin, hair, collagen, nutrition and beauty longevity. Clear ideas for people who want to understand how appearance changes with age and make better-informed choices over time.
Understand your skin, hair and body better without chasing every new trend, treatment or promise.
explore the Blog
